Literature DB >> 28246435

Elbasvir/grazoprevir.

.   

Abstract

Entities:  

Year:  2017        PMID： 28246435      PMCID： PMC5313242          DOI： 10.18773/austprescr.2017.010

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  9 in total

Review 1.  Ledipasvir with sofosbuvir.

Authors: 
Journal:  Aust Prescr       Date:  2015-10-14

Review 2.  Treating hepatitis C - what's new?

Authors:  Alex J Thompson; Jacinta A Holmes
Journal:  Aust Prescr       Date:  2015-09-18

3.  Paritaprevir/ritonavir/ombitasvir plus dasabuvir with ribavirin for chronic hepatitis C.

Authors: 
Journal:  Aust Prescr       Date:  2016-05-20

4.  Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.

Authors:  Gregory J Dore; Frederick Altice; Alain H Litwin; Olav Dalgard; Edward J Gane; Oren Shibolet; Anne Luetkemeyer; Ronald Nahass; Cheng-Yuan Peng; Brian Conway; Jason Grebely; Anita Y M Howe; Isaias N Gendrano; Erluo Chen; Hsueh-Cheng Huang; Frank J Dutko; David C Nickle; Bach-Yen Nguyen; Janice Wahl; Eliav Barr; Michael N Robertson; Heather L Platt
Journal:  Ann Intern Med       Date:  2016-08-09       Impact factor: 25.391

5.  Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agent.

Authors:  Xavier Forns; Stuart C Gordon; Eli Zuckerman; Eric Lawitz; Jose L Calleja; Harald Hofer; Christopher Gilbert; John Palcza; Anita Y M Howe; Mark J DiNubile; Michael N Robertson; Janice Wahl; Eliav Barr; Maria Buti
Journal:  J Hepatol       Date:  2015-04-18       Impact factor: 30.083

6.  Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.

Authors:  Stefan Zeuzem; Reem Ghalib; K Rajender Reddy; Paul J Pockros; Ziv Ben Ari; Yue Zhao; Deborah D Brown; Shuyan Wan; Mark J DiNubile; Bach-Yen Nguyen; Michael N Robertson; Janice Wahl; Eliav Barr; Joan R Butterton
Journal:  Ann Intern Med       Date:  2015-07-07       Impact factor: 51.598

7.  Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.

Authors:  Jürgen K Rockstroh; Mark Nelson; Christine Katlama; Jay Lalezari; Josep Mallolas; Mark Bloch; Gail V Matthews; Michael S Saag; Philippe J Zamor; Chloe Orkin; Jacqueline Gress; Stephanie Klopfer; Melissa Shaughnessy; Janice Wahl; Bach-Yen T Nguyen; Eliav Barr; Heather L Platt; Michael N Robertson; Mark Sulkowski
Journal:  Lancet HIV       Date:  2015-07-09       Impact factor: 16.070

8.  Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection.

Authors:  Paul Kwo; Edward J Gane; Cheng-Yuan Peng; Brian Pearlman; John M Vierling; Lawrence Serfaty; Maria Buti; Stephen Shafran; Paul Stryszak; Li Lin; Jacqueline Gress; Stuart Black; Frank J Dutko; Michael Robertson; Janice Wahl; Lisa Lupinacci; Eliav Barr; Barbara Haber
Journal:  Gastroenterology       Date:  2016-10-05       Impact factor: 33.883

9.  Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study.

Authors:  David Roth; David R Nelson; Annette Bruchfeld; AnnMarie Liapakis; Marcelo Silva; Howard Monsour; Paul Martin; Stanislas Pol; Maria-Carlota Londoño; Tarek Hassanein; Philippe J Zamor; Eli Zuckerman; Shuyan Wan; Beth Jackson; Bach-Yen Nguyen; Michael Robertson; Eliav Barr; Janice Wahl; Wayne Greaves
Journal:  Lancet       Date:  2015-10-05       Impact factor: 202.731
  9 in total
  1 in total

Review 1.  Sofosbuvir with velpatasvir.

Authors: 
Journal:  Aust Prescr       Date:  2017-08-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.